1938 related articles for article (PubMed ID: 7726138)
1. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas.
Gloghini A; Rizzo A; Zanette I; Canal B; Rupolo G; Bassi P; Carbone A
Am J Clin Pathol; 1995 Apr; 103(4):425-31. PubMed ID: 7726138
[TBL] [Abstract][Full Text] [Related]
2. KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases.
Carbone A; Gloghini A; Volpe R; Pinto A
Hum Pathol; 1993 Aug; 24(8):886-96. PubMed ID: 7690736
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
4. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.
Falini B; Flenghi L; Pileri S; Gambacorta M; Bigerna B; Durkop H; Eitelbach F; Thiele J; Pacini R; Cavaliere A
Am J Pathol; 1993 May; 142(5):1359-72. PubMed ID: 7684194
[TBL] [Abstract][Full Text] [Related]
5. CD68 reactivity of non-macrophage derived tumours in cytological specimens.
Doussis IA; Gatter KC; Mason DY
J Clin Pathol; 1993 Apr; 46(4):334-6. PubMed ID: 7684403
[TBL] [Abstract][Full Text] [Related]
6. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry.
Carbone A; Gloghini A; Colombatti A; Castronovo V; Ménard S
Hum Pathol; 1995 May; 26(5):541-6. PubMed ID: 7750938
[TBL] [Abstract][Full Text] [Related]
7. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
8. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
Kunisch E; Fuhrmann R; Roth A; Winter R; Lungershausen W; Kinne RW
Ann Rheum Dis; 2004 Jul; 63(7):774-84. PubMed ID: 15194571
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.
Warnke RA; Pulford KA; Pallesen G; Ralfkiaer E; Brown DC; Gatter KC; Mason DY
Am J Pathol; 1989 Dec; 135(6):1089-95. PubMed ID: 2688430
[TBL] [Abstract][Full Text] [Related]
11. KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker.
Dei Tos AP; Doglioni C; Laurino L; Fletcher CD
Histopathology; 1993 Aug; 23(2):185-7. PubMed ID: 8406391
[No Abstract] [Full Text] [Related]
12. Detection of interstitial increase in macrophages, characteristic of acute interstitial rejection, in routinely processed renal allograft biopsies using the monoclonal antibody KP1.
Dooper IM; Bogman MJ; Hoitsma AJ; Maass CN; Assmann KJ; Koene RA
Transpl Int; 1992 Sep; 5(4):209-13. PubMed ID: 1384532
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas.
Carbone A; Gloghini A; Zanette I; Canal B; Volpe R
Am J Clin Pathol; 1993 Mar; 99(3):289-97. PubMed ID: 8383422
[TBL] [Abstract][Full Text] [Related]
14. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.
Cassidy M; Loftus B; Whelan A; Sabt B; Hickey D; Henry K; Leader M
Virchows Arch; 1994; 424(6):635-40. PubMed ID: 7519954
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of macrophage-associated antigens (CD68 and Ki-M1P) by Schwann cells in reactive and neoplastic neural tissue. Light- and electron-microscopic findings.
Kaiserling E; Xiao JC; Ruck P; Horny HP
Mod Pathol; 1993 Jul; 6(4):463-8. PubMed ID: 8415593
[TBL] [Abstract][Full Text] [Related]
16. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
17. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
Binder SW; Said JW; Shintaku IP; Pinkus GS
Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
[TBL] [Abstract][Full Text] [Related]
18. Malignant hematopoietic breast tumors.
Lin Y; Govindan R; Hess JL
Am J Clin Pathol; 1997 Feb; 107(2):177-86. PubMed ID: 9024066
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
20. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
Wobser M; Roth S; Reinartz T; Rosenwald A; Goebeler M; Geissinger E
Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
